Prior caspofungin exposure in patients with hematological malignancies is a risk factor for subsequent fungemia due to decreased susceptibility in Candida spp.: A case-control study in Paris, France

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 11, 2011, Pages 5358-5361

  Blanchard, Elodie ^a,b,c   Lortholary, Olivier ^b,d,e   Boukris Sitbon, Karine ^b,d   Desnos Ollivier, Marie ^b,d   Dromer, Françoise ^b,d   Guillemot, Didier ^a,b,c   Bouges Michel, C ^f   Poilane, I ^g   Dunan, J ^h   Galeazzi, G ⁱ   Botterel, F ^j,n   Fauchet, N ^k   Forget, E ^l   Lawrence, C ^m   Bonnal, C ⁿ   Bouree P ⁿ   Eloy, O ^o   David, M F ^p   Khassis, N ^p   Milhaila, L ^p   Chachaty, E ^q   Chochillon, C ^r   Paugam, A ^s   Baixench, M T ^s   Cornet, M ^t   Escande, M C ^u   Bougnoux, M E ^v   Sterckers, Y ^v   Challier, S ^v   Dannaoui, E ^w   Lavarde, V ^w   Datry, A ^x   Lmimouni, B ^x   Brun, S ^x   Fekkar, A ^x   Poirot, J L ^y   Lacroix, C ^z   Moissenet, D ^aa   Develoux, M ^ab   Bonacorsi, S ^ac   Raoux, Dorothée ^ad   Hoinard, Damien ^ad   more..

^a INSERM U657   (France)

^b INSTITUT PASTEUR   (France)

^c University Versailles Saint Quentin UVSQ   (France)

^d CNRS   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f AVICENNE HOSPITAL   (France)

^g HÔPITAL JEAN VERDIER   (France)

^h HÔPITAL AMBROISE PARÉ   (France)

ⁱ HÔPITAL LOUIS MOURIER   (France)

^j HENRI MONDOR HOSPITAL   (France)

^k Centre Intercommunal   (France)

^l BEAUJON HOSPITAL   (France)

^m RAYMOND POINCARÉ HOSPITAL   (France)

ⁿ BICÊTRE HOSPITAL   (France)

^o CENTRE HOSPITALIER   (France)

^p HÔPITAL PAUL BROUSSE   (France)

^q INSTITUT GUSTAVE ROUSSY   (France)

^r BICHAT HOSPITAL   (France)

^s Hôpital Bichat ^*  (France)

^t HÔTEL DIEU   (France)

^u INSTITUT CURIE   (France)

^v HÔPITAL NECKER ENFANTS MALADES   (France)

^w HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^x PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^y HÔPITAL SAINT ANTOINE   (France)

^z SAINT LOUIS HOSPITAL   (France)

^aa ARMAND TROUSSEAU HOSPITAL   (France)

^ab HÔPITAL TENON   (France)

^ac HÔPITAL ROBERT DEBRÉ   (France)

^ad Hôpital Robert Debré ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN;

ACUTE LEUKEMIA; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; CANCER PATIENT; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDEMIA; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FRANCE; GROUPS BY AGE; HEMATOLOGIC MALIGNANCY; HUMAN; INFECTION RISK; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PICHIA GUILLIERMONDII; PRIORITY JOURNAL; YARROWIA LIPOLYTICA;

AGED; ANTIFUNGAL AGENTS; CANDIDA; CASE-CONTROL STUDIES; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; FEMALE; FRANCE; FUNGEMIA; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 80054709630     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00690-11     Document Type: Article

References (26)

1. Baixench, M.-T., et al. 2007. Acquired resistance to echinocandins in Candida albicans: case report and review. J. Antimicrob. Chemother. 59:1076-1083. (Pubitemid 47073317)
2. Charles, P. E., et al. 2005. Candida spp. colonization significance in critically ill medical patients: a prospective study. Intensive Care Med. 31:393-400.
3. Dannaoui, E., et al. 2010. Infections due to Candida spp. with reduced susceptibility to caspofungin in France, communication O-346. In Proceedings of the 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). European Society of Clinical Microbiology and Infectious Diseases, Basel, Switzerland.
4. Denning, D. W. 2003. Echinocandin antifungal drugs. Lancet 362:1142-1151. (Pubitemid 37222342)
5. Desnos-Ollivier, M., et al. 2008. Clonal population of flucytosine-resistant Candida tropicalis from blood cultures, Paris, France. Emerg. Infect. Dis. 14:557-565. (Pubitemid 351520856)
6. Desnos-Ollivier, M., et al. 2008. Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing. Antimicrob. Agents Chemother. 52:3092-3098.
7. Desnos-Ollivier, M., F. Dromer, and E. Dannaoui. 2008. Detection of caspofungin resistance in Candida spp. by Etest. J. Clin. Microbiol. 46:2389-2392.
8. Dizbay, M., et al. 2010. High incidence of Candida parapsilosis candidaemia in non-neutropenic critically ill patients: epidemiology and antifungal susceptibility. Scand. J. Infect. Dis. 42:114-120.
9. Forrest, G. N., E. Weekes, and J. K. Johnson. 2008. Increasing incidence of Candida parapsilosis candidemia with caspofungin usage. J. Infect. 56:126-129.
10. Garcia-Effron, G., S. Lee, S. Park, J. D. Cleary, and D. S. Perlin. 2009. Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint. Antimicrob. Agents Chemother. 53:3690-3699.
11. Hachem, R., H. Hanna, D. Kontoyiannis, Y. Jiang, and I. Raad. 2008. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer 112:2493-2499.
12. Horasan, E. S., et al. 2010. Increase in Candida parapsilosis fungemia in critical care units: a 6-years study. Mycopathologia 170:263-268.
13. Kabbara, N., et al. 2008. Breakthrough C. parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic stem cell transplant recipients receiving long-term caspofungin therapy. Haematologica 93:639-640. (Pubitemid 351536400)
14. Kofteridis, D. P., R. E. Lewis, and D. P. Kontoyiannis. 2010. Caspofungin-non-susceptible Candida isolates in cancer patients. J. Antimicrob. Chemother. 65:293-295.
15. Lortholary, O., et al. 2011. Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients. Antimicrob. Agents Chemother. 55:532-538.
16. Pappas, P. G., et al. 2009. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48:503-535.
17. Park, S., et al. 2005. Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates. Antimicrob. Agents Chemother. 49:3264-3273. (Pubitemid 41060570)
18. Perlin, D. S. 2011. Current perspectives on echinocandin class drugs. Future Microbiol. 6:441-457.
19. Perlin, D. S. 2007. Resistance to echinocandin-class antifungal drugs. Drug Resist. Updat. 10:121-130. (Pubitemid 47031054)
20. Pfaller, M., et al. 2011. Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Candida species to anidulafungin, caspofungin, and micafungin. J. Clin. Microbiol. 49:624-629.
21. Pfaller, M. A., M. Castanheira, S. A. Messer, G. J. Moet, and R. N. Jones. 2011. Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009). Diagn. Microbiol. Infect. Dis. 69:45-50.
22. Pfeiffer, C. D., et al. 2010. Breakthrough invasive candidiasis in patients on micafungin. J. Clin. Microbiol. 48:2373-2380.
23. Sipsas, N. V., et al. 2009. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer 115:4745-4752.
24. Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing. 2008. EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin. Microbiol. Infect. 14:398-405.
25. Sun, H.-Y., and N. Singh. 2010. Characterisation of breakthrough invasive mycoses in echinocandin recipients: an evidence-based review. Int. J. Antimicrob. Agents 35:211-218.
26. Walker, L. A., N. A. R. Gow, and C. A. Munro. 2010. Fungal echinocandin resistance. Fungal Genet. Biol. 47:117-126.